Fabian Kaske
About Fabian Kaske
Fabian Kaske is the CEO of Smile BI GmbH and Dr. Kaske GmbH & Co. KG, known for his contributions to digital pharma marketing and e-pharmacy analytics in Germany.
Current Positions
Fabian Kaske currently holds multiple positions. He serves as the CEO of Smile BI GmbH since 2019, based in Munich, Bavaria, Germany. Additionally, he leads Dr. Kaske GmbH & Co. KG as CEO from 2013, situated in the Munich area. His role in Business Development at Kreditech Holding SSL GmbH has been ongoing since 2012 in Hamburg. Furthermore, he has been involved in Brand Management at Procter & Gamble since 2011 in the Frankfurt am Main region. He also undertakes Strategy Consulting for Oliver Wyman since 2010, based in the greater New York City area.
Educational Background
Fabian Kaske's educational journey spans across several prestigious institutions. He conducted Ph.D. studies in Online Marketing at Universität Augsburg from 2013 to 2016. His academic credentials include a Master in Management from ESCP Business School and a Bachelor of Science in General Management from EBS Universität für Wirtschaft und Recht. Additionally, he studied at the City University of Hong Kong, National University of Singapore, and other international universities.
Leadership at Kaske Group
Under Fabian Kaske's leadership, the Kaske Group has established itself as a trusted partner for 8 of the top 10 pharmaceutical companies in digital marketing and sales. He has played a pivotal role in advancing the company's offerings and maintaining its position as a leader in the industry.
Development of Smile BI
Fabian Kaske oversees the Smile Analytics platform, which has gained recognition as the leading e-pharmacy analytics software in Germany. His strategic vision and execution have been instrumental in expanding Smile BI's market reach beyond Germany, enhancing its footprint and impact in the e-pharmacy sector.
Contributions to Digital Pharma Market Studies
Fabian Kaske regularly contributes to studies on the digital pharma market. These studies are frequently featured in prominent business journals such as Handelsblatt, FAZ, and Tagesschau. His insights and analyses play a significant role in shaping industry perspectives and guiding stakeholders in the digital pharma sector.
Role in Dr. Vital Establishment
Fabian Kaske played a key role in establishing Dr. Vital, the first white label direct-to-consumer provider in the pharma industry. This initiative marked a significant milestone in the pharma sector, offering a new business model and distribution channel for pharmaceutical products.